Eli Lilly Acquires Kelonia Therapeutics for Cancer Gene Therapy

{
  "signal_id": "258bacc5-ad52-8b61-6b90-dec3161c5d3e",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-10-05T20:30:14+00:00",
  "company": {
    "name": "Eli Lilly",
    "domain": "lilly.com"
  },
  "data": {
    "url": "https://denkstrom.org/en/goodnews/eli-lilly-acquires-kelonia-therapeutics-for-gene-therapy/",
    "title": "Eli Lilly Acquires Kelonia Therapeutics for Cancer Gene Therapy - Denkstrom",
    "excerpt": "Shareholders of Kelonia Therapeutics will receive up to 7 billion U.S. dollars under the acquisition agreement announced by Eli Lilly on April 20, 2026, including an upfront payment of 3.25 billion U.S. dollars and additional payments upon achievement of specific clinical, regulatory, and commercial milestones. The centerpiece is Kelonia's experimental gene therapy KLN-1010, which showed promise in early-stage clinical trials against relapsed or refractory multiple myeloma and other blood cancers, according to Eli Lilly's announcement.",
    "summary": "Eli Lilly and Company is set to acquire Kelonia Therapeutics in a deal valued at up to $7 billion, including a $3.25 billion upfront payment.",
    "planning": true,
    "image_url": "https://denkstrom.org/images/lilly-vereinbarte-im-april-2026-kelonia-kauf-fuer-krebsgentherapie.webp",
    "confidence": 0.95,
    "published_at": "2026-10-05T20:30:14Z",
    "article_sentence": "Shareholders of Kelonia Therapeutics will receive up to 7 billion U.S. dollars under the acquisition agreement announced by Eli Lilly on April 20, 2026, including an upfront payment of 3.25 billion U.S. dollars and additional payments upon achievement of specific clinical, regulatory, and commercial milestones.",
    "amount_normalized": 7000000000,
    "related_company_name": "Kelonia Therapeutics",
    "related_company_domain": "keloniatx.com"
  }
}

curl https://signals.autobound.ai/v1/signals/258bacc5-ad52-8b61-6b90-dec3161c5d3e \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"lilly.com","limit":20}'